The most notable companies in this group are Horizon Therapeutics Public Limited (NASDAQ:HZNP).
The investment seeks long-term capital appreciation.
The fund seeks to achieve its investment objective by primarily investing in equity, debt, and/or derivative securities of companies that the Adviser expects to benefit from an event catalyst. It may invest significantly in the common stock of and other interests (e.g., warrants) in special purpose acquisition companies or similar special purpose entities that pool funds to seek potential acquisition opportunities (collectively, “SPACs”). The fund may invest in SPACs for a variety of investment purposes, including to achieve income. It is non-diversified.
The average market capitalization across the NexPoint Event Driven C MF is 25.31B. The market cap for tickers in the group ranges from 331.91M to 26.78B. EXR holds the highest valuation in this group at 26.78B. The lowest valued company is USX at 331.91M.
The average weekly volume growth across all stocks in the NexPoint Event Driven C MF was 333%. For the same stocks of the MF, the average monthly volume growth was 137% and the average quarterly volume growth was 203%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 30
P/E Growth Rating: 67
Price Growth Rating: 54
SMR Rating: 72
Profit Risk Rating: 78
Seasonality Score: -13 (-100 ... +100)